▶ 調査レポート

世界の避妊具市場2022年-2027年:成長・動向・新型コロナの影響・市場予測

• 英文タイトル:Contraceptive Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Mordor Intelligenceが調査・発行した産業分析レポートです。世界の避妊具市場2022年-2027年:成長・動向・新型コロナの影響・市場予測 / Contraceptive Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) / MRC2203A312資料のイメージです。• レポートコード:MRC2203A312
• 出版社/出版日:Mordor Intelligence / 2022年1月
• レポート形態:英文、PDF、110ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥703,000 (USD4,750)▷ お問い合わせ
  Site Licence¥962,000 (USD6,500)▷ お問い合わせ
  Corporate License¥1,295,000 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Mordor Intelligence社の本市場調査レポートでは、世界の避妊具市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、種類別(コンドーム、ダイヤフラム、子宮頸管キャップ、スポンジ、膣リング)分析、性別(男性、女性)分析、地域別(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界の避妊具市場規模:種類別(コンドーム、ダイヤフラム、子宮頸管キャップ、スポンジ、膣リング)
・世界の避妊具市場規模:性別(男性、女性)
・世界の避妊具市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)
・競争状況(Allergan PLC、Bayer Healthcare、Cooper Surgical Inc.、…)
・市場機会・将来傾向

Recently, the use of contraceptive devices has been increasing due to an increasing number of unwanted pregnancies and the increasing awareness about sexually transmitted diseases (STDs).

Key Highlights

  • These factors have been primary drivers for the growth of the studied market. Moreover, initiatives by governments to raise awareness regarding contraceptives and family planning have also helped the growth of the market.
  • However, the side effects of contraceptive devices have been restraining the studied market’s growth.

Key Market Trends

Condoms are Expected to Dominate the Contraceptive Devices Market

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS. They also to a lesser extent protect against genital herpes, human papillomavirus (HPV), and syphilis.

The use of condoms has been increasing in not just the developing economies, but also developed countries. According to the U.S. Centers for Disease Control and Prevention Report, 2017, about one-third of the men or 33.7% said they used a condom the last time they had sex in the United States in 2017. This number had been reported to have increased from 29.5% in 2002, as per the report. Therefore, the increased use of condoms is expected to help the studied market’s growth.

North America is Expected to Dominate the Contraceptive Devices Market

North America is expected to register high growth, owing to the increasing prevalence of STDs, the high adoption rate of contraceptive devices, and the rising number of government initiatives that help in increasing the overall market.

According to the research article published, in 2018, “Contraceptive Use in the United States”, it had been estimated that about 62 million American women, used contraceptives in their childbearing years (15 years to 44 years). It had been observed that approximately 43 million of them (70%) are at risk of unintended pregnancy, i.e., they are sexually active and do not want to become pregnant; however, could become pregnant if they and their partners fail to use a contraceptive method correctly and consistently. As a result, the US government has initiated many programs to raise awareness regarding contraceptives.

The US Department of Health and Human Services launched a program, “Contraceptive Action Plan Project (CAP)”, in 2014. The main objective of the CAP is to reduce financial barriers to contraception, promote the most effective methods of birth control, and reduce unintended pregnancies in the United States. CAP’s main motto is to educate women about the birth control and better contraceptive options. Hence, with increase in unintended pregnancies and increase in government initiatives, the market studied is expected to register growth over the forecast period.

Competitive Landscape

The majority of the contraceptive devices are being manufactured by the global key players. Market leaders with more funds for research and a better distribution system have established their position in the market studied. Moreover, Asia-Pacific has been witnessing the emergence of some small players due to the rise of awareness. This has also helped the studied market to grow.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
レポート目次

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Awareness about Sexually Transmitted Diseases (STDs)
4.2.2 Rising Rate of Unintended Pregnancies
4.2.3 Rise in Government Initiatives
4.3 Market Restraints
4.3.1 Side Effects Associated with the Use of Contraceptive Devices
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Condoms
5.1.2 Diaphragms
5.1.3 Cervical Caps
5.1.4 Sponges
5.1.5 Vaginal Rings
5.1.6 Intra Uterine Device (IUD)
5.1.7 Other Types
5.2 By Gender
5.2.1 Male
5.2.2 Female
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allergan PLC
6.1.2 Bayer Healthcare
6.1.3 Cooper Surgical Inc.
6.1.4 Mylan Laboratories
6.1.5 Pfizer Inc.
6.1.6 Teva Pharmaceutical Industries Ltd
6.1.7 DKT International
6.1.8 Pregna International Limited
6.1.9 Reckitt Benckiser

7 MARKET OPPORTUNITIES AND FUTURE TRENDS